ILD - Does not meet expectations

Discussion in 'Boehringer Ingelheim' started by anonymous, Mar 1, 2024 at 4:26 AM.

Tags: Add Tags
  1. #1 anonymous, Mar 1, 2024 at 4:26 AM
    anonymous

    anonymous Guest

    Why so many bad MAGs this year?
     
    Quote

  2. #2 anonymous, Mar 1, 2024 at 8:15 AM
    anonymous

    anonymous Guest

    Don’t worry CES will right the ship
     
    Quote
  3. #3 anonymous, Mar 1, 2024 at 9:22 AM
    anonymous

    anonymous Guest

    Yes and accomplished virtually as well
     
    Quote
  4. #4 anonymous, Mar 1, 2024 at 9:32 AM
    anonymous

    anonymous Guest

    Just stay out of our way boomer.
     
    Quote
  5. #5 anonymous, Mar 1, 2024 at 1:47 PM
    anonymous

    anonymous Guest

    With CES taking over things will finally get done!
     
    Quote
  6. #6 anonymous, Mar 1, 2024 at 4:40 PM
    anonymous

    anonymous Guest

    That’s what they said about HSBS and IPF years ago- how’d that work out?
     
    Quote
  7. #7 anonymous, Mar 12, 2024 at 6:40 PM
    anonymous

    anonymous Guest

    No NDA for ILD so you better start looking for a new job ASAP
     
    Quote
  8. #8 anonymous, Mar 13, 2024 at 8:58 AM
    anonymous

    anonymous Guest

    It's only 2024, Einstein.
     
    Quote
  9. #9 anonymous, Mar 14, 2024 at 6:34 PM
    anonymous

    anonymous Guest

    No pediatric indication for you. You’ll be gone soon enough.
     
    Quote
  10. #10 anonymous, Mar 28, 2024 at 11:55 AM
    anonymous

    anonymous Guest

     
    Quote
  11. #11 anonymous, Mar 28, 2024 at 11:58 AM
    anonymous

    anonymous Guest

    The pediatric indication was an extreme long shot anyway with small financial profit if it happened. PDE4 will be another blockbuster so ILD will continue to be a key player for BI.
     
    Quote
Reply to Thread